K Paull

Proteolytic Inactivation of MAP-Kinase-Kinase by Anthrax Lethal Factor

Nicholas S. Duesbery, Craig P. Webb, Stephen H. Leppla et al. · Science · 1998 · 1K citations

Life Sciences, Biochemistry, Molecular Biology +13

Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel

Olivier Rixe, Waldo Ortuzar, Manuel Álvarez et al. · Biochemical Pharmacology · 1996 · 615 citations

Medicine, Oncology, Pharmacology +15

Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen.

J S Lee, K Paull, Curtis Hose et al. · Molecular Pharmacology · 1994 · 340 citations

Medicine, Oncology, Pharmacology +11

Reductase Enzyme Expression Across the National Cancer Institute Tumor Cell Line Panel: Correlation With Sensitivity to Mitomycin C and EO9

Sara A. Fitzsimmons, Paul Workman, Michael R. Grever et al. · JNCI Journal of the National Cancer Institute · 1996 · 235 citations · Full text

Life Sciences, Biochemistry, Oncology +17

P-Glycoprotein Substrates and Antagonists Cluster into Two Distinct Groups

Stefania Scala, Nadia Akhmed, U.S. Mahadeva Rao et al. · Molecular Pharmacology · 1997 · 231 citations

Medicine, Medicinal Chemistry, Pharmacology +13